Latest Medical News, Clinical Trials, Guidelines - Today on Medscape
Today on Medscape : Get the latest medical news, clinical trial coverage, drug updates, journal articles, CME activities & more on Medscape. A free resource for physicians.
Steps to Take for Diagnosing Cushing Syndrome - Medscape
2024年8月23日 · From Reincke M, Fleseriu M. Cushing syndrome: A review. JAMA. 2023;330:170-181.Source. Screen With These Biochemical Tests "Biochemical screening …
LGBTQ+ Care: The Medical Records Problem No One Talks About
2025年2月4日 · When Stewart O'Callaghan was diagnosed with chronic leukemia at the age of 29, they faced a lack of awareness of LGBTQ+ needs, interpersonal skills, and support …
Do We Really Know the Stroke Risk From AF? - Medscape
2025年2月4日 · There is growing evidence that the risk for stroke in patients with untreated AF is declining, changing the risk-benefit calculus for anticoagulation.
Self-Replicating mRNA Vaccine for COVID Prevention - Medscape
2024年12月13日 · Europe has approved two drugs for preventing COVID-19 infection: a monoclonal antibody and a self-amplifying mRNA vaccine.
Bad Behavior at Medical Conferences Prompts New Rules
2025年2月11日 · Speaker podiums and tables reserved for moderators had new paperwork waiting for delegates attending the Society of Thoracic Surgeons Annual Meeting this year as …
Low Bone Strength Even After Remission in Cushing Syndrome
2024年12月9日 · Although BMD values were comparable between patients with Cushing syndrome and controls, BMSi values were significantly lower in the Cushing syndrome cohort …
Beyond Anti-TNF: Is Ustekinumab a Better Choice in Crohn's?
2025年3月28日 · A significant reduction in faecal calprotectin values was also noted during follow-up (P = .0002). Among patients with perianal disease (n = 10), seven achieved clinical …
Is BMI Good for Anything These Days? Yes — At Least for Now
2024年12月31日 · Many experts, over many years, have questioned the value of using body mass index (BMI) to determine a patient’s health status. “A person’s health is influenced by a …
GLP-1 Benefits, Risks Detailed in ‘Atlas’ Mapping Outcomes
2025年1月23日 · A study of more than two million people with diabetes builds on evidence of broad-ranging benefits and risks of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) in …